PROJECT SUMMARY
Project name |
Improved diagnostics for visceral leishmaniasis: a prerequisite for elimination |
Project short-name |
VIP-CARE |
AMU project code |
EXT/BEL/TH03/CMHS/04/2017 |
Project phase |
I |
Partner countries |
Universiteit Antwerpen, Flemish Interuniversity Council (VLIR), Belgium |
AMU project coordinating office |
College of Medicine and Health Sciences |
Project type |
Research |
Project implementation location |
Jinka |
Target communities |
Visceral Leishmaniasis patients |
Project coordinator |
Dr Tamiru Shibiru |
Principal investigator |
Dr Tamiru Shibiru and Prof Nicole Berens-Riha |
Co-investigators |
Mr Dagmawie Tadesse. Prof Johan van Griensven |
Total project budget (Euro) |
69,718 |
Project start |
1-Sep-23 |
Project end |
31-Aug-25 |
Financial reporting period |
Quarterly |
Project finance management office |
CMHS finance & budget admin |
Progress reporting period |
quarterly |
Contact person (name and e-mail) |
Dr Tamiru Shibiru; |
PROJECT DESCRIPTION
Visceral leishmaniasis (VL) is among the deadliest neglected tropical diseases worldwide affecting the most impoverished populations. East-African countries accounted for 57% of the VL global burden in 2020. The WHO recently launched a VL elimination plan for East-Africa, with early detection and treatment of VL cases as the backbone to reduce transmission and VL burden. However, due to gaps in diagnostics and inaccessible healthcare the official numbers are just the tip of the iceberg and many patients remain untreated. Molecular diagnostics are promoted but their implementation in resource-constrained setting is very limited. We aim to ameliorate the research capacities and multidisciplinary collaboration of clinical, laboratory and anthropological researchers at Arba Minch University (AMU) and Jinka Hospital in southern Ethiopia to support independent and gender-equal research. Training on molecular techniques, good laboratory and clinical practice, interpretation and communication of results, evidence-based medicine and findings of the study will be organized at AMU and other health facilities. Trainees will train the next generation. In line with the elimination goals, we will define an improved and less-invasive diagnostic algorithm for VL patients which is acceptable and accessible for all. Therefore, a diagnostic study introducing molecular diagnostic in combination with a qualitative study with in-depth interviews of different stakeholders will be conducted. By investing in multistakeholder engagement though a community of practice, including patients, healthcare workers, researchers, policy makers and NGOs, we ensure uptake of research findings into policy and practice.